UCSF

ZINC00020228

Substance Information

In ZINC since Heavy atoms Benign functionality
September 27th, 2005 16 Yes

Other Names:

(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; (-)-2-(tert-butylamino)-3'-chloropropiophenone; 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-,(+-)-; CPD-3481; alpha-(tert-butylamino)-m-chloropropiophenone; amfebutamonum

(+-)-2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride; (+-)-alpha-tert-Butylamino-3-chloropropiophenone hydrochloride; 1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, hydrochloride, (+-)-; 2-(tert-Butylamino)-3'-chloropropiophenone

(+-)-Bupropion;Amfebutamona;Amfebutamone;Amfebutamonum;Wellbatrin;Wellbutrin;Zyban

(S)-bupropion

2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one

2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one hydrobromide

2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride

2-tert-Butylamino-1-(3-chloro-phenyl)-propan-1-one

31677-93-7; Bupropion hydrochloride (JAN/USP); D00817; Wellbutrin (TN); Zyban (TN)

31677-93-7; Bupropion hydrochloride; Prestwick_668

34841-39-9; Bupropion; C06860

34911-55-2; Bupropion (INN); D07591

612

905818-69-1; Bupropion hydrobromide (USAN); D07938

Amfebutamone

Amfebutamone (Bupropion)

Amfebutamone (Bupropion) HCl

Amfebutamone hydrochloride

Amfebutamone(Bupropion)

Aplenzin

BRD-A05186015-003-05-7

Bupropion

Bupropion hydrochloride

Bupropion (BAN

Bupropion (hydrochloride)

BUPROPION HCL

Bupropion Hydrobromide

BUPROPION HYDROCHLORIDE; CPD000058423; SAM001246723

Bupropion hydrocloride

Bupropion+naltrexone

BUPROPIONHYDROCHLORIDE

BW-323

BW-323U66

CPD000472526; AMFEBUTAMONE HCl; 31677-93-7

CPI-300

DCL000733

Elontril

FDA)

Forfivo XL

INN); Bupropion Hydrobromide (FDA

LS-194293

MFCD00055209

MFCD00865373

MFCD17014827

N/A

NA

QA-9977

Quomem

USAN

USAN); Bupropion HCl (FDA

USAN); Bupropion HCl (USAN

USAN); Bupropion Hydrochloride (FDA

USP

USP)

Voxra

Wellbatrin

Wellbutrin

Wellbutrin Retard

Wellbutrin SR

Wellbutrin XL

Wellbutrin XR

Wellbutrin, Zyban, Budeprion

Zyban

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.42 7 -38.47 2 2 1 34 240.754 4
Hi High (pH 8-9.5) 3.42 5.84 -6.53 1 2 0 29 239.746 4

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 4.032 Bitter DB
MP 222 TCI
ALOGPS_SOLUBILITY 6.93e-02 g/l DrugBank-approved
Purity 95% Fluorochem
Purity 95+% Matrix Scientific
biological_use Antidepressant IBScreen Bioactives IBScreen Bioactives
Target Dopamine Receptor Selleck Chemicals
mechanism Dopamine reuptake inhibitor IBScreen Bioactives
Patent Database Links EP1078637; EP1541197; EP1602369; EP1655029; EP1700601; EP1731142; EP1749525; EP1759701; EP1844769; EP1870096; EP1990639; US2002052340; US2002052341; US2004063742; US2004142904; US2004254182; US2005009870; US2005014786; US2005026946; US2005080087; US200528 ChEBI
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP03446b; 1 hydrogen chloride NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP03446b; SALT: 1 hydrogen chloride NIH Clinical Collection via PubChem
Therapy Selective dopamine reuptake inhibitor; antidepressant SMDC Iconix
biological_use Used as a smoking cessation aid IBScreen Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ACHA3-3-E Neuronal Acetylcholine Receptor Protein Alpha-3 Subunit (cluster #3 Of 5), Eukaryotic Eukaryotes 1000 0.53 Binding ≤ 10μM
ACHB2-4-E Neuronal Acetylcholine Receptor Protein Beta-2 Subunit (cluster #4 Of 7), Eukaryotic Eukaryotes 1000 0.53 Binding ≤ 10μM
SC6A2-1-E Norepinephrine Transporter (cluster #1 Of 2), Eukaryotic Eukaryotes 6970 0.45 Binding ≤ 10μM
SC6A3-1-E Dopamine Transporter (cluster #1 Of 3), Eukaryotic Eukaryotes 945 0.53 Binding ≤ 10μM
ACHA3-2-E Neuronal Acetylcholine Receptor Protein Alpha-3 Subunit (cluster #2 Of 3), Eukaryotic Eukaryotes 1800 0.50 Functional ≤ 10μM
ACHB2-1-E Neuronal Acetylcholine Receptor Protein Beta-2 Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 1800 0.50 Functional ≤ 10μM
ACHB4-1-E Neuronal Acetylcholine Receptor Protein Beta-4 Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 1800 0.50 Functional ≤ 10μM
ITA5-1-E Fibronectin Receptor Alpha (cluster #1 Of 1), Eukaryotic Eukaryotes 1800 0.50 Functional ≤ 10μM
Z104288-1-O Neuronal Acetylcholine Receptor; Alpha3/beta4 (cluster #1 Of 2), Other Other 1800 0.50 Binding ≤ 10μM
Z104282-1-O Acetylcholine Receptor; Alpha1/beta1/delta/gamma (cluster #1 Of 1), Other Other 7900 0.45 Functional ≤ 10μM
Z104288-1-O Neuronal Acetylcholine Receptor; Alpha3/beta4 (cluster #1 Of 1), Other Other 1800 0.50 Functional ≤ 10μM
Z50597-12-O Rattus Norvegicus (cluster #12 Of 12), Other Other 900 0.53 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
SC6A3_HUMAN Q01959 Dopamine Transporter, Human 441 0.56 Binding ≤ 1μM
ACHA3_HUMAN P32297 Neuronal Acetylcholine Receptor Protein Alpha-3 Subunit, Human 1000 0.53 Binding ≤ 1μM
ACHB2_HUMAN P17787 Neuronal Acetylcholine Receptor Protein Beta-2 Subunit, Human 1000 0.53 Binding ≤ 1μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 443 0.56 Binding ≤ 1μM
SC6A3_HUMAN Q01959 Dopamine Transporter, Human 1567 0.51 Binding ≤ 10μM
SC6A3_RAT P23977 Dopamine Transporter, Rat 1230 0.52 Binding ≤ 10μM
ACHA3_HUMAN P32297 Neuronal Acetylcholine Receptor Protein Alpha-3 Subunit, Human 1000 0.53 Binding ≤ 10μM
ACHB2_HUMAN P17787 Neuronal Acetylcholine Receptor Protein Beta-2 Subunit, Human 1000 0.53 Binding ≤ 10μM
Z104288 Z104288 Neuronal Acetylcholine Receptor; Alpha3/beta4 1800 0.50 Binding ≤ 10μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 1450 0.51 Binding ≤ 10μM
Z104282 Z104282 Acetylcholine Receptor; Alpha1/beta1/delta/gamma 7900 0.45 Functional ≤ 10μM
ITA5_HUMAN P08648 Fibronectin Receptor Alpha, Human 1800 0.50 Functional ≤ 10μM
ACHA3_HUMAN P32297 Neuronal Acetylcholine Receptor Protein Alpha-3 Subunit, Human 1800 0.50 Functional ≤ 10μM
ACHB2_HUMAN P17787 Neuronal Acetylcholine Receptor Protein Beta-2 Subunit, Human 1800 0.50 Functional ≤ 10μM
ACHB4_HUMAN P30926 Neuronal Acetylcholine Receptor Protein Beta-4 Subunit, Human 1800 0.50 Functional ≤ 10μM
Z104288 Z104288 Neuronal Acetylcholine Receptor; Alpha3/beta4 1800 0.50 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 2400 0.49 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Cell surface interactions at the vascular wall
Dopamine clearance from the synaptic cleft
Elastic fibre formation
Fibronectin matrix formation
Highly calcium permeable nicotinic acetylcholine receptors
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
Highly sodium permeable acetylcholine nicotinic receptors
Integrin cell surface interactions
Na+/Cl- dependent neurotransmitter transporters
Signal transduction by L1

Analogs ( Draw Identity 99% 90% 80% 70% )